CN110101614A - 一种富勒烯修复组合物及其制备方法 - Google Patents
一种富勒烯修复组合物及其制备方法 Download PDFInfo
- Publication number
- CN110101614A CN110101614A CN201910315082.1A CN201910315082A CN110101614A CN 110101614 A CN110101614 A CN 110101614A CN 201910315082 A CN201910315082 A CN 201910315082A CN 110101614 A CN110101614 A CN 110101614A
- Authority
- CN
- China
- Prior art keywords
- skin
- fullerene
- formula ratio
- preparation
- butanediol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种富勒烯修复组合物及其制备方法,该组合物由以下原料组分质量百比分制成:富勒烯0.01~5%、甜菜碱1~10%、丁二醇2~10%、神经酰胺1~15%、胆固醇1~10%、积雪草1~10%、透明质酸钠0.01~2%、余量为玫瑰花水。该制备方法包括以下步骤:(1)将配方量的玫瑰花水加热到75~85℃,加入配方量的丁二醇、甜菜碱、透明质酸钠搅拌溶解均匀得到混合体系;(2)将混合体系降温至45℃以下,加入配方量的富勒烯、神经酰胺、胆固醇及积雪草搅拌溶解均匀,得到成品。本发明具有降低致敏源,抑制炎症因子释放,能明显舒缓修复敏感处肌肤,改善皮肤敏感及瘙痒症状的功效。
Description
技术领域
本发明涉及护肤品技术领域,尤其涉及一种富勒烯修复组合物及其制备方法。
背景技术
“敏感性皮肤”是一种比正常皮肤具有更高反应性,并且对外界因素的微弱影响产生剧烈反应的皮肤类型。它具有敏感性高、耐受性差和易反应性等三大特点。目前敏感性皮肤的发生有不断增多的趋势,得到了皮肤科学界的关注。它是一种高度敏感的皮肤状态,易受到外部因素的影响而产生刺痛、烧灼、紧绷、瘙痒等感觉,可伴有或不伴有临床体征。由于敏感性皮肤对外界环境变化感受性较高,使得其在皮肤护理、日用化妆品使用方面有较高要求,因此预先了解皮肤状态对于正确选择化妆品及皮肤护理方法就显得尤为重要;对于化妆品开发与研究者而言,找到合适的与自身定位匹配的敏感性皮肤群体进行日用化妆品的测试也极其重要。
敏感性皮肤的发生不是独立简单的,而是一个复杂的综合原因的结果。
首先,内在因素,影响皮肤敏感的内在因素众多,包括了种族、现有疾病、性别、年龄等,有目前认为皮肤敏感程度的不同可能与肤色有关,肤色较浅者血管反应性更强,较易发生皮肤敏感。另有研究也认为肤色浅的受试者比肤色深者更容易出现皮肤敏感。通常女性更容易抱怨皮肤不适,有研究认为女性较男性更容易出现皮肤敏感,这可能是由于男女皮肤结构的不同引起,男性表皮厚度显著大于女性,同时因为男女激素水平的差异,会使女性对炎症反应更加敏感。在年龄方面,年轻人比老年人更容易出现皮肤敏感,原因可能是老年人的皮肤不仅存在感觉神经功能减退,而且存在神经分布的减少。
其次,生活中很多人会在气候变化、季节交替、日晒,使用化妆品后,或者无明显诱因,出现皮肤瘙痒、紧绷、烧灼、刺痛等不适,皮肤处于一种高度敏感的状态。以往对敏感性皮肤的认识较少,容易被研究人员忽视,因为它往往只是一种难以量化的主观刺激感,没有明显可见的皮肤表现。随着不断研究,人们进一步认识到敏感性皮肤不是严格意义上的皮肤疾病,而被认为是一种高度敏感的皮肤状态,处于这种状态的皮肤易受到各种物理化学因素的刺激而产生刺痛、烧灼、紧绷、瘙痒等感觉。
还有地域不同,气候干燥,气温不同,温差也不同,人的角质层含水量也会不同。经研究气温低,干燥的皮肤会更容易过敏。
为减少皮肤受到不良反应的化妆品刺激而导致皮肤出现红肿、发痒及过敏性皮炎等异常现象,本发明以私人基因来定制护肤产品的理念,根据不同的人皮肤基因检测报告、皮肤生理学、皮肤病理学、皮肤当下状况、季节、年龄、地域七个维度科学设计定制护肤方案,采用富勒烯作为主要功效活原料配制而成,以降低致敏源,抑制炎症因子释放,修复敏感肌肤。
发明内容
针对现有技术的不足,本发明所解决的技术问题是如何降低致敏源,抑制炎症因子释放,修复敏感肌肤。
为解决上述技术问题,本发明采用的技术方案是一种富勒烯修复组合物,由以下原料组分质量百比分制成:富勒烯0.01~5%、甜菜碱1~10%、丁二醇2~10%、神经酰胺1~15%、胆固醇1~10%、积雪草1~10%、透明质酸钠0.01~2%、余量为玫瑰花水。
本发明要解决的另一个技术问题是提供上述富勒烯修复组合物的制备方法
为此,本发明提供的技术方案是一种富勒烯修复组合物制备方法,包括以下步骤:
(1)将配方量的玫瑰花水加热到75~85℃,加入配方量的丁二醇、甜菜碱、透明质酸钠搅拌溶解均匀得到混合体系;
(2)将混合体系降温至45℃以下,加入配方量的富勒烯、神经酰胺、胆固醇及积雪草搅拌溶解均匀,得到成品。
与现有技术产品相比,本发明产品具有降低致敏源,抑制炎症因子释放,能明显修复皮肤屏障,舒缓修复敏感处肌肤,在一定程度上减轻皮肤损伤,改善皮肤敏感及瘙痒症状的功效。
具体实施方式
下面结合实施例对本发明的具体实施方式作进一步的说明,但不是对本发明的限定。
实施例1至3配方见下表1:
上述实施例1至3通过以下方法制备:
(1)将配方量的玫瑰花水加热到75~85℃,加入配方量的丁二醇、甜菜碱、透明质酸钠搅拌溶解均匀得到混合体系;
(2)将混合体系降温至45℃以下,加入配方量的富勒烯、神经酰胺、胆固醇及积雪草搅拌溶解均匀,得到成品。
为体现本发明功效设置了对照实验,在具体使用时,将本发明实施例1至3制备的组合物添加至护肤品中,添加量占化妆品质量的10%~70%。可根据制备舒缓修复类化妆品的常规工艺及辅料,制备成精华液、乳液、膏霜等护肤化妆品。
实验方法:筛选出至少10名面部为敏感肌肤或者正处于过敏(发红、发痒)的人群(18~45岁)作为敏感肌肤志愿者,通过空白对照,在脸部涂抹本发明实施例组合物后,分别在第0天、第7天和第14天进行测试,测其皮肤水分含量、皮肤水分流失量、皮肤颜色、皮肤血红素值,这些指标是用来评价皮肤屏障功能及使用产品后,皮肤的修复能力。
本实验共招募志愿者20名,有效志愿者为20名且数据有效。测试共进行了2周,在使用样品前后均检测皮肤水分含量、皮肤水分流失量、皮肤血红素值,比较其区别,结果分别如表2~4所示。
表2,皮肤水分含量表:
实验结果:从表中可看出,与对照侧相比,使用样品2周后,样品侧的皮肤水分含量有明显的增加。
表3,皮肤水分流失表:
实验结果:从表中可看出,与对照测相比,使用样品2周后,样品侧的皮肤水分流失明显下降。
表4,皮肤血红素值表:
选取一个没有加组合物的基料护肤品作对照组。
实验结果:从表中可看出,使用后,样品组与对照组的皮肤血红素值均有显著增加,而样品组的增加量显著低于对照组。即样品在一定程度上具有减轻皮肤损伤的症状。
通过上述结果可以看出,使用本发明组合物制备的化妆品,2周后就能明显修复皮肤屏障,舒缓修复敏感处肌肤,在一定程度上减轻皮肤损伤,改善皮肤敏感及瘙痒症状。
以上结合实施例对本发明的实施方式做出了详细说明,但本发明不局限于所描述的实施方式。对于本领域技术人员而言,在不脱离本发明的原理和精神的情况下,对这些实施方式进行各种变化、修改、替换和变型仍落入本发明的保护范围内。
Claims (2)
1.一种富勒烯修复组合物,其特征在于,由以下原料组分质量百比分制成:富勒烯0.01~5%、甜菜碱1~10%、丁二醇2~10%、神经酰胺1~15%、胆固醇1~10%、积雪草1~10%、透明质酸钠0.01~2%、余量为玫瑰花水。
2.一种如权利要求1所述的富勒烯修复组合物的制备方法,其特征在于,包括以下步骤:
(1)将配方量的玫瑰花水加热到75~85℃,加入配方量的丁二醇、甜菜碱、透明质酸钠搅拌溶解均匀得到混合体系;
(2)将混合体系降温至45℃以下,加入配方量的富勒烯、神经酰胺、胆固醇及积雪草搅拌溶解均匀,得到成品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910315082.1A CN110101614A (zh) | 2019-04-18 | 2019-04-18 | 一种富勒烯修复组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910315082.1A CN110101614A (zh) | 2019-04-18 | 2019-04-18 | 一种富勒烯修复组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110101614A true CN110101614A (zh) | 2019-08-09 |
Family
ID=67485839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910315082.1A Withdrawn CN110101614A (zh) | 2019-04-18 | 2019-04-18 | 一种富勒烯修复组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110101614A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110721135A (zh) * | 2019-11-29 | 2020-01-24 | 广州欧正化妆品技术研究院有限公司 | 一种具有保湿修复抗衰功效的含富勒烯固态浓缩干面膜及其制备方法 |
CN110742852A (zh) * | 2019-11-15 | 2020-02-04 | 上海百好博化工有限公司 | 一种用于多效修复敏感肌肤的组合物及制备方法与用途 |
CN111419793A (zh) * | 2020-04-29 | 2020-07-17 | 上海紫河生物科技有限公司 | 一种含富勒烯及其衍生物的滴眼液及其制备方法 |
-
2019
- 2019-04-18 CN CN201910315082.1A patent/CN110101614A/zh not_active Withdrawn
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110742852A (zh) * | 2019-11-15 | 2020-02-04 | 上海百好博化工有限公司 | 一种用于多效修复敏感肌肤的组合物及制备方法与用途 |
CN110721135A (zh) * | 2019-11-29 | 2020-01-24 | 广州欧正化妆品技术研究院有限公司 | 一种具有保湿修复抗衰功效的含富勒烯固态浓缩干面膜及其制备方法 |
CN111419793A (zh) * | 2020-04-29 | 2020-07-17 | 上海紫河生物科技有限公司 | 一种含富勒烯及其衍生物的滴眼液及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schwartz et al. | Ingestion of BioCell Collagen®, a novel hydrolyzed chicken sternal cartilage extract; enhanced blood microcirculation and reduced facial aging signs | |
Child et al. | A study of the spectrum of skin disease occurring in a black population in south‐east London | |
CN110101614A (zh) | 一种富勒烯修复组合物及其制备方法 | |
Fox et al. | In vivo skin hydration and anti-erythema effects of Aloe vera, Aloe ferox and Aloe marlothii gel materials after single and multiple applications | |
CN1148334A (zh) | 柔和的抗粉刺组合物 | |
Tagami et al. | Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products | |
CN114917178A (zh) | 适用于沙漠干燥肌肤的舒缓修护组合物及其应用 | |
Wendling et al. | Skin biophysical properties of a population living in Valais, Switzerland | |
Addor | Topical effects of SCA®(Cryptomphalus aspersa secretion) associated with regenerative and antioxidant ingredients on aged skin: evaluation by confocal and clinical microscopy | |
Trookman et al. | Clinical assessment of a combination lip treatment to restore moisturization and fullness | |
Mazzarello et al. | Werner syndrome: quantitative assessment of skin aging | |
Crisan et al. | Ultrasonographic assessment of the cutaneous changes induced by topical flavonoid therapy | |
Aruan et al. | Double-blind, randomized trial on the effectiveness of Acetylhexapeptide-3 cream and Palmitoyl Pentapeptide-4 cream for crow's feet | |
CN113749974A (zh) | 一种清痘修护面膜及其制备方法 | |
Dall’Oglio et al. | Clinical and instrumental evaluation of a new topical non-corticosteroid antifungal/anti-inflammatory/antiseborrheic combination cream for the treatment of mild-to-moderate facial seborrheic dermatitis | |
Bergera-Virassamynaïk et al. | Evaluation of the Efficacy of an Ecobiological Dermo-Cosmetic Product to Help Manage and Prevent Relapses of Eyelid Atopic Dermatitis | |
CN105853293A (zh) | 具有美白作用的化妆品组合物及护手霜 | |
CN108703917B (zh) | 一种抗衰老组合物及其制备的化妆品 | |
Wakeman | An open-label forearm-controlled pilot study to assess the effect of a proprietary emollient formulation on objective parameters of skin function of eczema-prone individuals over 14 days | |
CN108721154A (zh) | 一种用于皮肤保湿和屏障修复的护肤品及其制备方法 | |
CN107095804A (zh) | 一种茶籽萃取油润肤霜及其制备方法 | |
Safa et al. | A prospective, open-label study to evaluate the impact of VYC-12L injection on skin quality attributes in healthy volunteers | |
Draelos et al. | A 14-day Controlled Study Assessing Qualitative Improvement with 15% Lactic Acid and Ceramides in Skin Moisturization and Desquamation | |
Celleno et al. | Structure and function of the skin | |
CN111407770A (zh) | 一种治疗皮肤病的组合物及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190809 |
|
WW01 | Invention patent application withdrawn after publication |